<DOC>
	<DOCNO>NCT02848469</DOCNO>
	<brief_summary>The Irish Omega-3 study clinical trial design investigate potential Omega-3 fatty acid reduction risk psychosis . The study coordinate HRB Clinical Research Facility University College Cork . The Principal Investigator Dr Maeve Rooney , Consultant Psychiatrist Mercy University Hospital , Cork . The study carry collaboration HRB Clinical Research Facility Dublin prior roll centre around Ireland . The Study fund Stanley Medical Research Institute , non-profit organization support research cause , treatment , schizophrenia bipolar disorder . It large provider funding research serious mental illness outside U.S. government .</brief_summary>
	<brief_title>Irish Omega-3 Study</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<criteria>Subjects age 13 50 year . Written inform consent obtain subject , , case eighteen , parent guardian , assent participant . Subjects meet criterion UHR , accord Structured Interview Prodromal Syndromes ( SIPS ) ( Cannon et al. , 2008 , Woods et al. , 2009 ) . Previous psychotic episode least one week 's duration . Previous manic episode least one week 's duration . Acute suicidal aggressive behaviour . Substance dependence . Lactose intolerance/Milk allergy Intellectual disability , opinion investigator would affect person 's ability participate trial . Previous treatment antipsychotic mood stabiliser psychiatric indication longer 2 week previous three month . Consumption counter prescribe omega3 fatty acid supplement within 12 week enter trial . Pregnancy/breastfeeding . Severe intercurrent illness may affect ability participant take part trial .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>